HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soonmyung Paik Selected Research

desintegron B

10/2016Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor-Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14.
5/2011Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20.
4/2010Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20.
12/2004A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Soonmyung Paik Research Topics

Disease

75Breast Neoplasms (Breast Cancer)
01/2021 - 06/2002
60Neoplasms (Cancer)
10/2021 - 06/2002
9Colonic Neoplasms (Colon Cancer)
10/2021 - 03/2010
6Colorectal Neoplasms (Colorectal Cancer)
04/2019 - 10/2008
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2016
4Stomach Neoplasms (Stomach Cancer)
12/2019 - 06/2017
3Squamous Cell Carcinoma of Head and Neck
12/2020 - 02/2015
3Neoplasm Metastasis (Metastasis)
12/2019 - 10/2019
3Adenocarcinoma of Lung
01/2018 - 10/2015
3Microsatellite Instability
06/2017 - 03/2007
3Neutropenia
09/2015 - 06/2008
2Residual Neoplasm
01/2020 - 01/2020
2Triple Negative Breast Neoplasms
01/2020 - 07/2014
2Pathologic Complete Response
12/2019 - 06/2008
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2018 - 11/2017
2Noninfiltrating Intraductal Carcinoma (DCIS)
09/2017 - 04/2012
2Heart Failure
11/2013 - 10/2005
1Ovarian Neoplasms (Ovarian Cancer)
01/2020
1Margins of Excision
12/2019
1Diarrhea
12/2019
1Urinary Tract Infections (Urinary Tract Infection)
01/2019
1Arthralgia (Joint Pain)
01/2019
1Left Ventricular Dysfunction
01/2019
1Back Pain (Backache)
01/2019
1Adenocarcinoma
10/2018
1Second Primary Neoplasms (Neoplasms, Second)
07/2018
1Carcinoma (Carcinomatosis)
11/2017
1Mesothelioma
11/2017
1Melanoma (Melanoma, Malignant)
11/2017
1Brain Neoplasms (Brain Tumor)
11/2017
1Extranodal Extension
09/2017

Drug/Important Bio-Agent (IBA)

22Estrogen ReceptorsIBA
10/2020 - 12/2002
21TamoxifenFDA LinkGeneric
01/2019 - 10/2002
18Trastuzumab (Herceptin)FDA Link
10/2020 - 06/2002
14Biomarkers (Surrogate Marker)IBA
04/2020 - 12/2002
12ParaffinIBA
10/2021 - 12/2004
12Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 06/2002
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2019 - 06/2002
11Doxorubicin (Adriamycin)FDA LinkGeneric
12/2019 - 06/2002
10Hormones (Hormone)IBA
01/2020 - 12/2006
8B 31IBA
10/2020 - 06/2002
8Proteins (Proteins, Gene)FDA Link
01/2018 - 06/2002
7Formaldehyde (Formol)FDA Link
10/2021 - 05/2005
7Progesterone Receptors (Progesterone Receptor)IBA
10/2020 - 06/2010
7human ERBB2 proteinIBA
07/2018 - 01/2007
6Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2019 - 12/2012
5Docetaxel (Taxotere)FDA Link
07/2017 - 05/2006
4AnthracyclinesIBA
01/2020 - 01/2008
4ErbB Receptors (EGF Receptor)IBA
01/2020 - 11/2015
4Messenger RNA (mRNA)IBA
10/2019 - 06/2007
4Leucovorin (Folinic Acid)FDA Link
04/2019 - 09/2010
4Fluorouracil (Carac)FDA LinkGeneric
04/2019 - 09/2010
4RNA (Ribonucleic Acid)IBA
01/2018 - 06/2008
4Bevacizumab (Avastin)FDA Link
01/2018 - 07/2013
4desintegron BIBA
10/2016 - 12/2004
4Estrogens (Estrogen)FDA Link
04/2012 - 06/2010
3DNA (Deoxyribonucleic Acid)IBA
10/2021 - 07/2013
3Biological ProductsIBA
11/2020 - 04/2010
3CateninsIBA
01/2020 - 04/2019
3GemcitabineFDA Link
09/2015 - 06/2008
3Raloxifene Hydrochloride (Evista)FDA Link
01/2015 - 11/2011
3Selective Estrogen Receptor Modulators (SERM)IBA
01/2015 - 11/2011
2Immune Checkpoint InhibitorsIBA
08/2020 - 06/2017
2Pharmaceutical PreparationsIBA
04/2020 - 09/2013
2neratinibIBA
01/2020 - 12/2019
2KYA1797KIBA
01/2020 - 04/2019
2taxaneIBA
01/2020 - 09/2013
2Lapatinib (GW572016)FDA Link
10/2019 - 11/2013
2Aromatase InhibitorsIBA
01/2019 - 12/2006
2Letrozole (Femara)FDA LinkGeneric
01/2019 - 12/2006
2dacomitinibIBA
12/2015 - 02/2015
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2015 - 12/2004
2P-2 (P 2)IBA
01/2015 - 07/2013
2Dihydrotachysterol (AT 10)IBA
04/2012 - 08/2006
2Monoclonal AntibodiesIBA
10/2008 - 10/2008
1Programmed Cell Death 1 ReceptorIBA
01/2021
1NVP-BKM120IBA
12/2020
1Cetuximab (Erbitux)FDA Link
12/2020
1AntigensIBA
08/2020
1Interferon Type IIBA
08/2020
1Immune Checkpoint ProteinsIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
12/2019
1Vacuolar Proton-Translocating ATPases (V-Type ATPase)IBA
11/2018
1IDF-11774IBA
11/2018
1AD 11IBA
10/2018
1Doxycycline (Periostat)FDA LinkGeneric
01/2018
1Nicotinamide PhosphoribosyltransferaseIBA
01/2018
1Eosine Yellowish-(YS) (Eosin)IBA
09/2017
1Hematoxylin (Haematoxylon)IBA
09/2017
1Phosphotransferases (Kinase)IBA
06/2017
1MucinsIBA
06/2017
1tyrosine receptor (receptor, tyrosine)IBA
06/2017

Therapy/Procedure

43Therapeutics
01/2021 - 02/2003
25Drug Therapy (Chemotherapy)
10/2020 - 01/2003
16Adjuvant Chemotherapy
10/2020 - 10/2005
7Neoadjuvant Therapy
01/2020 - 06/2008
4Segmental Mastectomy (Lumpectomy)
12/2019 - 10/2002
1Mastectomy (Mammectomy)
12/2019
1Intraperitoneal Injections
01/2018
1Immunotherapy
11/2017